Prostate Solutions
Bibliography
[1] Hambrock T, Futterer J, Henkjan JH, Hulsbergen-vandeKaa C, vanBasten JP, vanOort I, Witjes JA, Barentsz JO; "Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility", Investigative Radiology, 43(686), 686-694 (2008).
[2] Hambrock T, "Value of 3 Tesla multimodality-directed MR-guided biopsy to detect prostate cancer in high-risk patients after at least two previous negative biopsies", Proc. RSNA SSK08-01 (2008).
[3] Beyersdorff D, Winkel A, Hamm B, Lenk S, Loening S, Taupitz M, "MR imaging-guided prostate biopsy with a closed MR unit at 1.5T: initial results", Radiology 234(2), 577-581 ( 2005).
[4] National Comprehensive Cancer Network, "Practice Guidelines in Oncology" – v.2.2009, www.nccn.org, accessed 7/15/2009.
[5] American Cancer Society, "What are the key statistics about prostate cancer?", http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_are_the_key_statistics_for_prostate_cancer_36.asp, accessed 10/10/08.
[6] Hambrock T, Somford DM, Hoeks C, Bouwense SAW, Huisman H, Yakar D, van Oort IM, Witjes JA, Futterer JJ, Barentsz JO, "Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen". The Journal of Urology, 183:520-528 (2010).
[7] Hodge KK, McNeal JE, Terris MK, et al, "Random systemic versus directed ultrasound guided transrectal core biopsies of the prostate". J Urol 142:71-74, (1989).
[8] Bostwick DG, "Prostate needle biopsy: Squeezing information from threads of tissue". Semin Urol Oncol, 17:175-176 (1999).
[9] Aetna Clinical Policy Bulletin: Prostate Saturation Biopsy, www.aetna.com/cpb/medical/data/600_699/0698.html, accessed January 4, 2010
[10] Kim JK, Jang YJ, Cho G, "Multidisciplinary functional MR imaging for prostate cancer". Korean J Radiol, 10(6)535-552 (2009).
[11] Kurhanewicz J, Thomas A, Jajodia P, Weiner M, James TL, Vigneron DB, Narayan P. P-31 Spectroscopy of the Human Prostate Gland In Vivo using a Transrectal Probe. Magn Res Med. 1991;22(2):403-413.
[12] Personal verbal communication, R. Princenthal and P. Choyke, May, 2009.
[13] Choi YJ, Kim JK, Kim N, Kim KW, Choi EK, Cho KS. Functional MR imaging of prostate cancer. Radiographics. 2007;27:63–75.
[14] D'Arcy JA, Collins DF, Padhami AR, Wlaker-Samuel S, Suckling J, Leach M, "Magnetic resonance imaging workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data". RadioGraphics, 26:621-632 (2006).
[15] Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, Kraitchman DL, "Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory and current state of the art", Journal of Cardiovascular Magnetic Resonance, 10:1-18 (2008).
[16] Prando A, Kurhanewicz J, Borges AP, Oliveira EM, Jr., Figueiredo E. Prostatic Biopsy Directed with Endorectal MR Spectroscopic Imaging Findings in Patients with Elevated Prostate Specific Antigen Levels and Prior Negative Biopsy Findings: Early Experience. Radiology 2005; 236:903-910.
[17] Partin AW, "Does sextant prostate biopsy provide adequate sampling for early detection of prostate cancer?", Current Urology Reports, 1:245 (2000).